top of page


Mode Sensors secures new grant
Mode Sensors Receives RFF Grant for Clinical Validation of Re:Balans hydration monitoring

Martin Engebretsen
May 281 min read
Â
Â


Mode Sensors launches new clinical trial for Re:Balans® hydration monitoring wearable
Mode Sensors (MODE) is pleased to announce the initiation of a new clinical trial at Solfjellhøgda Rehabilitation Centre, focusing on the...

Martin Engebretsen
Jan 251 min read
Â
Â


Re:Balans® wearable in scientific journal
Mode Sensors (MODE) is proud to announce that its Re:Balans hydration wearable tracking technology has been featured in a peer-reviewed...

Jesper Jakobsen
Jan 81 min read
Â
Â


Lockheed Martin invests in Re:Balans® hydration monitoring wearable
Hydration monitoring may play a critical role in mission success and safety in military aviation. Mode Sensors (MODE) has signed a $1.78...

Jesper Jakobsen
Dec 10, 20241 min read
Â
Â


Patent granted for Re:Balans® hydration monitoring wearable
Mode Sensors (MODE) is proud to announce the granting of a patent for its innovative hydration monitoring technology in Norway under...

Martin Engebretsen
Nov 20, 20241 min read
Â
Â


Re:Balans® in peer-reviewed journal
Re:Balans Hydration Monitoring Technology Featured in Peer-Reviewed Journal Mode Sensors (MODE) is pleased to announce that its...

Jesper Jakobsen
Nov 20, 20241 min read
Â
Â


Mode achieves ISO 13485 certification
Mode Sensors (MODE) is proud to announce its certification under ISO 13485, the internationally recognized standard for quality...

Jesper Jakobsen
Jun 27, 20241 min read
Â
Â


Mode grants contract with leading U.S. medical device company
Mode Sensors (MODE) is pleased to announce a collaboration agreement with a leading U.S. medical device manufacturer to test Re:Balans...

Jesper Jakobsen
Mar 28, 20241 min read
Â
Â


Granted €2.5 from EU Horizon for hydration monitoring wearable
Mode Sensors is granted 2,5 million euros from the EU's 2020 Horizon Program, with an additional 2 million euro "blended-finance"...

Martin Engebretsen
Nov 13, 20221 min read
Â
Â
bottom of page